Al-Yousif, Nameer
Nouraie, Seyed M.
Broerman, Matthew J.
Zhang, Yingze
Suber, Tomeka L.
Evankovich, John
Bain, William G.
Kitsios, Georgios D.
McVerry, Bryan J.
Shah, Faraaz A. http://orcid.org/0000-0002-2847-7738
Funding for this research was provided by:
National Institutes of Health (K23GM122069)
NHLBI Division of Intramural Research (P01HL114453)
National Institutes of Health (R03 HL162655)
Biomedical Laboratory Research and Development, VA Office of Research and Development (IK2 BX004886)
Article History
Received: 15 September 2023
Accepted: 21 February 2024
First Online: 5 March 2024
Declarations
:
: Informed consent is obtained from patients or their legally authorized representatives under study protocol STUDY19050099 approved by the University of Pittsburgh Institutional Review Board.
: All authors have reviewed the manuscript and consent to submission for publication.
: Georgios Kitsios has received research funding from Karius, Inc., and Pfizer, Inc. Seyed Nouraie has received research funding from Pfizer, Inc. Bryan McVerry has received research funding from Bayer Pharmaceuticals, Inc., and consulting fees from Boehringer Ingelheim, Synairgen, and BioAegis.